Shan Yao1, Yi Wei1, Zheng Ye1, and Bin Song1
1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China
Synopsis
Hepatocellular carcinoma (HCC) is the most
common malignancy cancer and
the second major contributor to cancer-related mortality worldwide. Diffusion-weighted imaging (DWI) has been widely used in HCC evaluation and showed great potential, while with some limitations like low SNRs and artifacts causing by high b values, and prolonged acquisition time. Synthetic DWI is mathematically derived from directly acquired DWI with at least two different b-values,
which may tackle the limitations of conventional acquired DWI. This study aims to
investigate the clinical feasibility and diagnosis performance of synthetic DWI
in patients with HCC compared with conventional acquired DWI qualitatively and quantitatively.
INTRODUCTION
Hepatocellular carcinoma (HCC) is the most
common malignancy cancer with fast rising incidence in both men and women and
the second major contributor to cancer-related mortality worldwide1, 2. Diffusion-weighted
imaging (DWI), an unenhanced, robust and reliable technique which has been
widely used in the evaluation of liver tumors and showed its usefulness and
potential in HCC diagnosis3-6. However,
acquired high b-value results in low signal-to-noise ratios (SNRs) and artifacts
such as eddy current-induced distortions, with prolonged acquisition time as requirement
of longer echo times (TEs)7. By
contrast, synthetic DWI is a mathematical computation technique using derived apparent
diffusion coefficient (ADC) and acquired b-values to synthesize desired
b-values images with at least two different b-values7,
which may tackle the limitations of conventional directly acquired DWI by
achieving background suppression of a very high b-value DWI without additional
acquisition scan time. Though previous studies have demonstrated the usefulness
of synthetic DWI in detection of prostate cancers, pancreatic cancers, hepatic
metastases, and breast cancers8-15, almost
no study has focused on synthetic DWI in HCC evaluation. Therefore, the purpose
of this study is to investigate the clinical feasibility and diagnosis performance
of synthetic DWI in patients with HCC compared with conventional acquired DWI qualitatively
and quantitatively.
METHODS
This prospective study was approved by the Institutional
Review Board with written informed consent obtained. Twenty-seven patients with HCC were prospectively
involved undergoing conventional acquired DWI at b-values of 50, 800, 1000, 1200,
and 1400 s/mm2 and synthetic DWI, of which synthetic images were
calculated at b=1000, 1200, and 1400 s/mm2 from acquired images
using b-values of 200 and 600 s/mm2. Two readers reviewed image sets
of both synthetic and conventional acquired images of 1000, 1200, and 1400 s/mm2
independently and rated image quality and lesion conspicuity. Overall image
quality was assessed using 4-point scale: 1=poor, 2=moderate, 3=good, 4=excellent,
and lesion conspicuity based on 5-point scale: 1=barely conspicuous, 2=fairly conspicuous,
3=moderately conspicuous, 4=well seen, 5=very well and sharply defined. Signal
intensity (SI) was measured by placing round regions of interest (ROIs) on
lesions and liver parenchyma avoiding any focal lesions and major vessels.
Quantitative analysis was performed as follows: signal-to-noise ratio (SNR) = SIlesion
/ SDbackground noise, contrast-to-noise ratio (CNR) = (SIlesion - SIliver parenchyma) / SDbackground noise, SIR=
SIlesion / SIliver parenchyma, cancer-to-parenchyma
contrast ratio =(SIliver parenchyma - SIlesion) / (SIliver
parenchyma + SIlesion). The grading scores at different b values
were compared using the Friedman test. SNR, CNR, and SIR were compared using analysis
of variance. In case of significant results, post-hoc analysis was performed. The
interobserver agreement were also evaluated by intraclass correlation
coefficient (ICC) for quantitative assessment. Two-sided p value <0.05 was considered
as statistically significant.
RESULTS
There were no significant differences in overall image quality at synthetic DWI1000, conventional
DWI1000, synthetic DWI1200, and conventional DWI1200
(p>0.05), whereas synthetic DWI1400 showed lower overall image
quality than other DWI sets (p<0.001). Comparison of lesion conspicuity at both
synthetic and conventional acquired three DWI sets revealed no significant
differences (p>0.05). SNR, CNR and SIR showed a continuous decrease with
increasing b-values, with significant differences between each of b-values sets
(P<0.001), while comparison between synthetic DWI1000 and conventional
DWI1000, synthetic DWI1200 and conventional DWI1200,
synthetic DWI1400 and conventional DWI1400 presented no
significant difference (p>0.05). Cancer-to-parenchyma contrast ratio almost
unchanging showed no significant difference (p>0.05). Both readers showed
similar assessment in SNR, CNR, SIR and cancer-to-parenchyma contrast ratio at
all DWI sets, with moderate to good interobserver agreement (ICC=0.63-0.81,
P<0.05).
CONCLUSION
Synthetic DWI is of great comparable image
quality and lesion conspicuity in HCC diagnosis versus conventional acquired DWI,
while reducing scan time and avoiding the disadvantages of performing DWI at high b-values.Acknowledgements
No acknowledgement found.References
REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer
statistics, 2019. CA Cancer J Clin 2019;69(1):7-34.
2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,
2015. Ca Cancer J Clin 2016;66(2):115-32.
3. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold
diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions
compared with dynamic contrast-enhanced MRI alone using receiver operating
characteristic curve analysis. J Magn Reson Imaging 2009;29(2):341-9.
4. Saito K, Araki Y, Park J, et al. Effect of Gd-EOB-DTPA on
T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular
carcinoma. J Magn Reson Imaging 2010;32(1):229-34.
5. Nishie A, Tajima T, Ishigami K, et al. Detection of
hepatocellular carcinoma (HCC) using super paramagnetic iron oxide
(SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI). J Magn
Reson Imaging 2010;31(2):373-82.
6. Rimola J, Forner A, Sapena V, et al. Performance of gadoxetic
acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence
of hepatocellular carcinoma. Eur Radiol 2020;30(1):186-94.
7. Blackledge MD, Leach MO, Collins DJ, Koh DM. Computed
diffusion-weighted MR imaging may improve tumor detection. Radiology
2011;261(2):573-81.
8. Rosenkrantz AB, Chandarana H, Hindman N, et al. Computed
diffusion-weighted imaging of the prostate at 3 T: impact on image quality and
tumour detection. Eur Radiol 2013;23(11):3170-7.
9. Jendoubi S, Wagner M, Montagne S, et al. MRI for prostate
cancer: can computed high b-value DWI replace native acquisitions? Eur Radiol
2019;29(10):5197-204.
10. Fukukura Y, Kumagae Y, Hakamada H, et al. Computed
diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma:
Comparison with acquired diffusion-weighted imaging. Eur J Radiol
2017;95:39-45.
11. Shimizu H, Isoda H, Fujimoto K, et al. Comparison of acquired
diffusion weighted imaging and computed diffusion weighted imaging for
detection of hepatic metastases. Eur J Radiol 2013;82(3):453-8.
12. Kawahara S, Isoda H, Fujimoto K, et al. Additional benefit of
computed diffusion-weighted imaging for detection of hepatic metastases at
1.5T. Clin Imaging 2016;40(3):481-5.
13. Bickel H, Polanec SH, Wengert G, et al. Diffusion-Weighted MRI of
Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic
b-Values. J Magn Reson Imaging 2019;50(6):1754-61.
14. Daimiel Naranjo I, Lo Gullo R, Saccarelli C, et al. Diagnostic
value of diffusion-weighted imaging with synthetic b-values in breast tumors:
comparison with dynamic contrast-enhanced and multiparametric MRI. Eur Radiol
2020.
15. Choi BH, Baek HJ, Ha JY, et al. Feasibility Study of Synthetic
Diffusion-Weighted MRI in Patients with Breast Cancer in Comparison with
Conventional Diffusion-Weighted MRI. Korean J Radiol 2020;21(9):1036-44.